Preprint / Version 1

Analyzing Cardiovascular Disease Risk Assessments: Improving Cultural Competence for Asian Americans

##article.authors##

  • Aarti Chaudhary Polygence

DOI:

https://doi.org/10.58445/rars.862

Keywords:

cardiovascular, healthcare, CVD, asian, risk calculator

Abstract

Cultural competency in healthcare, specifically cardiology, needs to be improved because of inaccurate information about screening processes, which doesn’t help many ethnicities. The Atheroscletoric Cardiovascular Disease (ASCVD) risk calculator is commonly used in primary care offices to determine whether or not someone should be taking extra precautions to avoid disease. The primary groups that research has previously focused on to prove the effectiveness of the calculator were white, black, and Hispanic groups. Though other ethnicities were considered, they were all grouped into an “Other” category, so the actual effectiveness is not shown. As a result, other patients may get inaccurate information about their risk for cardiovascular diseases and suffer more. This paper will review current research on different cardiovascular disease risk assessments and analyze whether or not they are accurate for the Asian American population. By researching other calculators that can help Asian Americans, and using the ASCVD risk calculator as a benchmark, the paper will be able to help improve healthcare.

References

Becoming a Culturally Competent Health Care Organization: AHA. American Hospital Association. (2013). https://www.aha.org/ahahret-guides/2013-06-18-becoming-culturally-competent-health-care-organization#:~:text=Cultural%20competency%20in%20health%20care,social%2C%20cultural%20and%20linguistic%20needs

Centers for Disease Control and Prevention. (2023, May 15). Heart disease facts. Centers for Disease Control and Prevention. https://www.cdc.gov/heartdisease/facts.htm#:~:text=Heart%20disease%20is%20the%20leading,groups%20in%20the%20United%20States.&text=One%20person%20dies%20every%2033,United%20States%20from%20cardiovascular%20disease.&text=About%20695%2C000%20people%20in%20the,1%20in%20every%205%20deaths

Goff, D.C., Lloyd-Jones, D.M., Bennett, G., Coady, S., D’Agostino, R.B., Gibbons, R., Greenland, P., Lackland, D.T., Levy, D., O’Donnell, C.J., Robinson, J.G., Schwartz, J.S., Shero, S.T., Smith, S.C., Sorlie, P., Stone, N.J., Wilson, P.W.F. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2014 Jul, 63 (25_Part_B) 2935–2959.

https://doi.org/10.1016/j.jacc.2013.11.005

Jamthikar, A. D., Gupta, D., Johri, A. M., Mantella, L. E., Saba, L., Kolluri, R., Sharma, A. M., Viswanathan, V., Nicolaides, A., & Suri, J. S. (2020). Low-Cost Office-Based Cardiovascular Risk Stratification Using Machine Learning and Focused Carotid Ultrasound in an Asian-Indian Cohort. Journal of medical systems, 44(12), 208. https://doi.org/10.1007/s10916-020-01675-7

Khanna, N.N., Jamthikar, A.D., Gupta, D., Nicolaides, A., Araki, T., Saba, L., Cuadrado-Godia, E., Sharma, A., Omerzu, T., Suri, H.S., Gupta, A., Mavrogeni, S., Turk, M., Laird, J.R., Protegerou, A., Sfikakis, P.P., Kitas, G.D., Viswanathan, V., & Suri, J.S. (2019, January). Performance evaluation of 10-year ultrasound image-based stroke/cardiovascular (CV) risk calculator by comparing against ten conventional CV risk calculators: A diabetic study, Computers in Biology and Medicine, Volume 105, 2019, Pages 125-143, ISSN 0010-4825, https://doi.org/10.1016/j.compbiomed.2019.01.002.

Krishnan, S. (2019, May 17). South Asians and Cardiovascular Disease: The Hidden Threat. American College of Cardiology. https://www.acc.org/Latest-in-Cardiology/Articles/2019/05/07/12/42/Cover-Story-South-Asians-and-Cardiovascular-Disease-The-Hidden-Threat

Ramsey, S. (2021, February 2). CVD Risk Calculation: Can Smaller Clinics Break Through?. KPWHRI. https://www.kpwashingtonresearch.org/news-and-events/recent-news/news-2021/cvd-risk-calculation-can-smaller-clinics-break-through

U.S. Department of Health and Human Services. (n.d.). BIOLINCC: Framingham Heart Study (FHS). National Heart Lung and Blood Institute. https://biolincc.nhlbi.nih.gov/studies/fhs/

U.S. Department of Health and Human Services. (n.d.). Framingham Heart Study (FHS). National Heart Lung and Blood Institute. https://www.nhlbi.nih.gov/science/framingham-heart-study-fhs#:~:text=When%20it%20launched%20in%201948,that%20contribute%20to%20cardiovascular%20disease

Viswanathan, V., Jamthikar, A. D., Gupta, D., Puvvula, A., Khanna, N. N., Saba, L., Viskovic, K., Mavrogeni, S., Turk, M., Laird, J. R., Pareek, G., Miner, M., Ajuluchukwu, J., Sfikakis, P. P., Protogerou, A., Kitas, G. D., Nicolaides, A., Sharma, A., & Suri, J. S. (2020). Integration of estimated glomerular filtration rate biomarker in image-based cardiovascular disease/stroke risk calculator: a south Asian-Indian diabetes cohort with moderate chronic kidney disease. International angiology : A Journal of the International Union of Angiology, 39(4), 290–306. https://doi.org/10.23736/S0392-9590.20.04338-2

Wilson, P. W. F. (2023). Framingham risk score for hard coronary heart disease. MDCalc. https://www.mdcalc.com/calc/38/framingham-risk-score-hard-coronary-heart-disease

World Health Organization. (2023). Cardiovascular diseases. World Health Organization. https://www.who.int/health-topics/cardiovascular-diseases#tab=tab_1

Zhu, L., Singh, M., Lele, S., Sahakian, L., Grossman, J., Hahn, B., & McMahon, M. (2022). Assessing the validity of QRISK3 in predicting cardiovascular events in systemic lupus erythematosus. Lupus science & medicine, 9(1), e000564. https://doi.org/10.1136/lupus-2021-000564

Downloads

Posted

2024-01-06

Categories